# NRX Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d6530909-2858-4af5-9a0e-221ebe170a7e | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/nrx-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-09T04:46:40.724359+00:00 | | Last reviewed | 2026-10-09T04:46:40.724359+00:00 | ## Identity - Legal name: NRX Pharmaceuticals, Inc. - Display name: NRX Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-09T22:21:36.092052+00:00 | | Completeness | 0.409 | | Record Quality | 0.835 | | Directors | 5 | | Committees | 5 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Chaim Hurvitz: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:5 - Dennis McBride, Ph.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:6 - Jonathan Javitt, M.D., M.P.H.: Director. Status: current. Independent: false. Since: 2015-01-01. claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:7 - Michael Taylor: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:8 - Patrick J. Flynn: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:9 ## Committees - Audit (audit). Chair: Patrick J. Flynn. Members: Patrick J. Flynn (chair, current); Chaim Hurvitz (member, current); Michael Taylor (member, current); Patrick J. Flynn (chair, unknown); Chaim Hurvitz (member, unknown); Michael Taylor (member, unknown). committee_id=alpha:committee:nrx-pharmaceuticals-inc:audit - Audit · Chair; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Patrick J. Flynn (member, current). committee_id=alpha:committee:nrx-pharmaceuticals-inc:audit-chair-compensation-chair - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Chaim Hurvitz (member, current); Michael Taylor (member, current). committee_id=alpha:committee:nrx-pharmaceuticals-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: Patrick J. Flynn. Members: Patrick J. Flynn (chair, current); Chaim Hurvitz (member, current); Michael Taylor (member, current); Patrick J. Flynn (chair, unknown); Chaim Hurvitz (member, unknown); Michael Taylor (member, unknown). committee_id=alpha:committee:nrx-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Chaim Hurvitz (member, current); Michael Taylor (member, current); Chaim Hurvitz (member, unknown); Michael Taylor (member, unknown). committee_id=alpha:committee:nrx-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Jonathan Javitt, M.D., M.P.H.: Chairman, Chief Executive Officer and Chief Scientist [CEO]. Status: current. claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:10 - Joseph Casper: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:11 - Matthew Duffy: Chief Business Officer. Status: current. claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:12 - Michael Abrams: Chief Financial Officer and Treasurer [CFO]. Status: current. claim_id=alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:13 ## Governance events - CEO_CHANGED: Jonathan Javitt, M.D., M.P.H. executive of NRX Pharmaceuticals, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:eoz0kv10bq1iv - EXECUTIVE_APPOINTED: Joseph Casper executive of NRX Pharmaceuticals, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:1gp60ep1nfbbc1 - EXECUTIVE_APPOINTED: Matthew Duffy executive of NRX Pharmaceuticals, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:13voruh8zqcgt - CFO_CHANGED: Michael Abrams executive of NRX Pharmaceuticals, Inc., effective 2026-03-23. Effective: 2026-03-23. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:o2kz2q1pbvzqq - DIRECTOR_APPOINTED: Michael Taylor seat on NRX Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:xgcdt2ivw7q - COMMITTEE_MEMBER_ADDED: Michael Taylor member of Audit; Compensation; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:1x1hnfc18ys4uq - DIRECTOR_APPOINTED: Dennis McBride, Ph.D. seat on NRX Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:15h6677ovjilh - DIRECTOR_APPOINTED: Chaim Hurvitz seat on NRX Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:ra967f19kf6vr - DIRECTOR_APPOINTED: Patrick J. Flynn seat on NRX Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:gketq31959zj7 - COMMITTEE_CREATED: Audit · Chair; Compensation · Chair committee of NRX Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:1ic5cvvgzcssj - COMMITTEE_MEMBER_ADDED: Patrick J. Flynn member of Audit · Chair; Compensation · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:7fywptwhuflp - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of NRX Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:i6r2zjwki51j - COMMITTEE_MEMBER_ADDED: Chaim Hurvitz member of Audit; Compensation; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:edyq0fbf3jq7 - DIRECTOR_APPOINTED: Jonathan Javitt, M.D., M.P.H. seat on NRX Pharmaceuticals, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-09T04:46:40.724359+00:00. event_id=alpha:event:transition:5bjbhqmr2p8a ## Scoped resources - `alpha://company/nrx-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record - `alpha://company/nrx-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/nrx-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/nrx-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=board - `alpha://company/nrx-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/nrx-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/nrx-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/nrx-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/nrx-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/nrx-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/nrx-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/nrx-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/nrx-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/nrx-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/nrx-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/nrx-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/nrx-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/nrx-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/nrx-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/nrx-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=events - `alpha://company/nrx-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/nrx-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/nrx-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:patrick-j-flynn","name":"Patrick J. Flynn"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:chaim-hurvitz","name":"Chaim Hurvitz"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:michael-taylor","name":"Michael Taylor"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:patrick-j-flynn","name":"Patrick J. Flynn"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:chaim-hurvitz","name":"Chaim Hurvitz"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-taylor","name":"Michael Taylor"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:chaim-hurvitz","name":"Chaim Hurvitz"},"source_id":"board_seats"}` - Claim alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:michael-taylor","name":"Michael Taylor"},"source_id":"board_seats"}` ## Leadership - Chaim Hurvitz: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fba2b12ca4731b66b60ff5900f1350f36b4b993177ec25d096bbaf7c37f912de. - Dennis McBride, Ph.D.: Director. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:6. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fba2b12ca4731b66b60ff5900f1350f36b4b993177ec25d096bbaf7c37f912de. - Jonathan Javitt, M.D., M.P.H.: Director. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fba2b12ca4731b66b60ff5900f1350f36b4b993177ec25d096bbaf7c37f912de. - Michael Taylor: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fba2b12ca4731b66b60ff5900f1350f36b4b993177ec25d096bbaf7c37f912de. - Patrick J. Flynn: Director, Audit · Chair; Compensation · Chair. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fba2b12ca4731b66b60ff5900f1350f36b4b993177ec25d096bbaf7c37f912de. - Jonathan Javitt, M.D., M.P.H.: Chairman, Chief Executive Officer and Chief Scientist. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:10. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:efe8abd48151736ca4b346365a713edce4ca6c9ff195eacf2624e06e308ce320. - Joseph Casper: Chief Operating Officer. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:11. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:579699de18767b2f892724753829e291c51dfcb3f04a58f2123126c83c130691. - Matthew Duffy: Chief Business Officer. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:12. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:14c5c6afa7f2060cc4ea349ae44ee760b35814f72ecb8b9beb5b5500c22b0749. - Michael Abrams: Chief Financial Officer and Treasurer. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:leadership_role:13. Valid from: 2026-03-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:28937e1eca28eea31e9c1285c5fadeb0f10a1d2227f4ad11cc3badddce5c6fd3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Patrick J. Flynn; Members Patrick J. Flynn (Chair); Chaim Hurvitz; Michael Taylor. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Compensation: Chair Patrick J. Flynn; Members Patrick J. Flynn (Chair); Chaim Hurvitz; Michael Taylor. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Nominating and Governance: Chair not stated; Members Chaim Hurvitz; Michael Taylor. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - NRX Pharmaceuticals, Inc.. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:69fa872fc248487808441a36a0875d5690c9e2f7e6474c0f3283d13415a30841. ## Entity Status - Public listing published. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:69fa872fc248487808441a36a0875d5690c9e2f7e6474c0f3283d13415a30841. ## Published Fact - US. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:69fa872fc248487808441a36a0875d5690c9e2f7e6474c0f3283d13415a30841. ## Committee Appointment - Patrick J. Flynn: chair, Audit. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Chaim Hurvitz: member, Audit. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Michael Taylor: member, Audit. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Patrick J. Flynn: chair, Compensation. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Chaim Hurvitz: member, Compensation. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Michael Taylor: member, Compensation. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Chaim Hurvitz: member, Nominating and Governance. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. - Michael Taylor: member, Nominating and Governance. Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f. ## Security Listing - NRXP (NASDAQ). Claim: alpha:claim:company:d6530909-2858-4af5-9a0e-221ebe170a7e:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:69fa872fc248487808441a36a0875d5690c9e2f7e6474c0f3283d13415a30841. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:69fa872fc248487808441a36a0875d5690c9e2f7e6474c0f3283d13415a30841: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc). - alpha:projection-evidence:document:fba2b12ca4731b66b60ff5900f1350f36b4b993177ec25d096bbaf7c37f912de: [NRX Pharmaceuticals, Inc. DEF 14A 2026-02-23](https://www.sec.gov/Archives/edgar/data/1719406/000143774926005119/nrxp20260218_def14a.htm). - alpha:projection-evidence:document:efe8abd48151736ca4b346365a713edce4ca6c9ff195eacf2624e06e308ce320: [NRXP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1719406/000143774926009418/nrxp20251231_10k.htm). - alpha:projection-evidence:document:579699de18767b2f892724753829e291c51dfcb3f04a58f2123126c83c130691: [NRXP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1719406/000143774926009418/nrxp20251231_10k.htm). - alpha:projection-evidence:document:14c5c6afa7f2060cc4ea349ae44ee760b35814f72ecb8b9beb5b5500c22b0749: [NRXP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1719406/000143774926009418/nrxp20251231_10k.htm). - alpha:projection-evidence:document:28937e1eca28eea31e9c1285c5fadeb0f10a1d2227f4ad11cc3badddce5c6fd3: [NRXP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1719406/000143774926009418/nrxp20251231_10k.htm). - alpha:projection-evidence:ebb1f49e026e654a899ba3e90c7157467fa187b4b18ffa056737b202a913fe3f: [Audit](https://www.sec.gov/Archives/edgar/data/1719406/000143774926005119/nrxp20260218_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/nrx-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/nrx-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/nrx-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/nrx-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-09T22:21:36.114756+00:00; recorded 2026-10-09T22:21:36.114756+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.